Table 1.
TB notification, follow-up and treatment outcome during the COVID-19 periods.
| Periods | p value | |||
|---|---|---|---|---|
| Control | intensive | regular | ||
| Notification | ||||
| Laboratory confirmed cases (%) | 68996/129782 (53•2%) |
52935/103230 (51•3%) |
26898/52922 (50•8%) |
<0•0001 |
| Migrant cases (%) | 38072/129782 (29•3%) |
26136/103320 (25•3%) |
13611/52922 (25•7%) |
<0•0001 |
| Follow-up examination | ||||
| Sputum examination after 2 months treatment (%) | 94198/136963 (68•8%) |
70183/116509 (60•2%) |
20684/31917 (64•8%) |
<0•0001 |
| Sputum examination after full treatment course (%) | 97274/178314 (54•6%) |
67264/144984 (46•4%) |
26311/52892 (49•7%) |
<0•0001 |
| Treatment outcome of smear positive | ||||
| Sputum conversion rate after 2 months treatment (%) | 41716/44816 (93•1%) |
33165/35423 (93•6%) |
8771/9548 (91•9%) |
0•7475 |
| Cured rate (%) | 44252/51998 (85•1%) |
33862/39992 (84•7%) |
10997/12988 (84•7%) |
0•6159 |